Sign In

Credits/Points Offered

  • Continuing Medical Education (CME): 10.50 AMA PRA Category 1 Credits
  • Maintenance of Certification (MOC): 10.50 Points

Accreditation and Designation Statements

Continuing Medical Education (CME)
The American Association for the Study of Liver Diseases (AASLD) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AASLD designates this live activity for a maximum of 10.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification (MOC)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

CME Credits

Physicians and other health care professionals seeking AMA PRA Category 1 Credits™ for this live continuing medical education activity must complete an evaluation by Monday, October 16, 2017. A link to the CME evaluation will be emailed to attendees after the meeting.

Certificates will only be issued to those who complete an evaluation by the deadline; requests for CME will not be honored after Monday, October 16, 2017. CME certificates will be emailed upon successful completion of the evaluation.

MOC Points

Physicians seeking ABIM MOC points must complete the CME evaluation in addition to a MOC evaluation by Monday, October 16, 2017. Requests for MOC after this date will not be honored. A link to the MOC evaluation will be available for completion after the meeting on Saturday, September 16.

MOC points will be reported to the ABIM at the end of September 2017 for attendees who successfully complete the MOC evaluation.

Conference Description/Needs Statement

To provide updated information on Acute on Chronic Liver Failure (ACLF) syndrome including its pathogenesis and evolving therapies.

Learning Objectives

  • Upon completion of this activity, learners will be able to:
  • To discuss the diagnosis and natural history of ACLF
  • To understand the pathophysiology of ACLF
  • To learn about the therapies for the various organ failures that are part of the syndrome of ACLF
  • To develop strategies for the prevention of ACLF

Target Audience

  • Hepatologists
  • Gastroenterologists
  • Mid-level Providers
  • Pharmacists
  • Transplant Coordinators
  • Surgeons
  • Fellows / Trainees
  • Industry Representatives
  • Intensive Care Physicians
  • Physician Assistants
  • Government/Regulatory Representatives
  • Industry Representatives

Core Competencies

  • Medical Knowledge
  • Evidence-based Practice
  • Patient Care